OHD Learn · Provider Type Guide

Dialysis Facilities

For people with kidney failure, dialysis machines do what the kidneys no longer can — filtering waste and fluid from the blood, on a regular schedule, for as long as it takes.

A lifeline for people whose kidneys no longer function.

End-stage renal disease (ESRD) is permanent kidney failure — the kidneys can no longer filter waste and excess fluid from the blood on their own. For the roughly 560,000 Americans on dialysis,1 treatment is not a recovery plan. It is a permanent, ongoing medical necessity.

Most dialysis patients visit an outpatient center three times a week for hemodialysis — a process where a machine performs the function the kidneys can no longer do, filtering blood over the course of three to four hours per session. Some patients are trained to perform dialysis at home, either through home hemodialysis or peritoneal dialysis, which uses the lining of the abdomen as a filter. A minority of patients receive a kidney transplant and are removed from dialysis entirely.

Because nearly all ESRD patients are covered by Medicare — regardless of age, a unique provision in federal law — the federal government has both visibility and financial incentive to closely track what happens in these facilities.


A single star rating derived from clinical outcomes, patient voices, and lab data.

CMS publishes a Five-Star Quality Rating for each dialysis facility through the Dialysis Facility Care Compare (DFCC) program. The rating compresses a wide range of performance data into a single score.

⭐⭐⭐⭐⭐
Dialysis Facility Care Compare — Five-Star Quality Rating
A composite score combining clinical outcomes, patient experience, and dialysis adequacy. Facilities are rated 1 (lowest) to 5 (highest) relative to national performance.
Component 1
Clinical Outcomes
Standardized ratios for mortality, hospitalization, readmission, transfusion, and infection — each comparing actual outcomes to what was predicted given the facility's patient population. A ratio below 1.0 means fewer events than expected.
Component 2
Patient Experience (ICH CAHPS)
Results from the In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems survey — a federally mandated patient survey covering how well nephrologists communicate, how patients rate the staff, and how they rate the facility overall.
Component 3
Dialysis Adequacy (Kt/V)
The percentage of patients achieving adequate dialysis, measured by Kt/V — a ratio capturing how thoroughly waste products are cleared from the blood each session. Consistently low Kt/V is associated with significantly worse survival outcomes.
📊
Clinical Outcomes — Standardized Ratios
The clinical outcomes component is built from five standardized ratios — each comparing what actually happened at a facility to what was predicted given its patient population. Risk adjustment accounts for patient age, diagnoses, time on dialysis, and dialysis modality, making cross-facility comparisons meaningful even when patient populations differ. A ratio below 1.0 means fewer events than expected. Each ratio carries a category designation — better than expected, as expected, or worse than expected — alongside confidence intervals.
Survival & Utilization
  • Standardized Mortality Ratio (SMR) — deaths actual vs. predicted
  • Standardized Hospitalization Ratio (SHR) — admissions per 100 patient-years
  • Standardized Readmission Ratio (SRR) — readmissions as % of discharges
Transfusion & Infection
  • Standardized Transfusion Ratio (STrR) — transfusions per 100 patient-years
  • Standard Infection Ratio (SIR) — bloodstream infections actual vs. predicted
  • Confidence intervals and patient counts for each ratio
💬
Patient Experience (ICH CAHPS)
The In-Center Hemodialysis CAHPS survey is administered twice a year — fall and spring — covering six domains. Each domain is reported with lower, middle, and top-box percentages, a linearized composite score, and a domain-level star rating. This is the only component that comes directly from patients rather than clinical records or claims.
  • Nephrologists' communication and caring
  • Quality of dialysis center care and operations
  • Providing information to patients
  • Overall rating of the nephrologist
  • Overall rating of the dialysis center staff
  • Overall rating of the dialysis facility
  • Survey response rate and total completed interviews
🔬
Dialysis Adequacy (Kt/V)
Kt/V is the core clinical measure of whether a patient is receiving enough dialysis — K is the dialyzer clearance rate, t is treatment time, and V is the volume of the patient's body water. CMS sets minimum thresholds: ≥1.2 for hemodialysis, ≥1.7 for peritoneal dialysis. Reported separately for adult and pediatric populations across both modalities.
  • Adult HD patients with Kt/V ≥ 1.2 — % and patient count
  • Adult PD patients with Kt/V ≥ 1.7 — % and patient count
  • Pediatric HD patients with Kt/V ≥ 1.2
  • Pediatric PD patients with Kt/V ≥ 1.8
  • Rolling 12-month patient-months for each population

Five measures that exist outside the Five-Star score.

The Five-Star rating captures survival, patient experience, and dialysis adequacy — but the full dataset goes further. These measures track aspects of care that matter clinically and operationally, and appear in the underlying data regardless of what the composite rating shows.

🩺
Vascular Access
How a patient connects to the dialysis machine determines their infection risk and long-term outcomes. An arteriovenous fistula is the preferred access — surgically created, lowest infection risk, longest lifespan. A long-term catheter is the least preferred: prone to infection and associated with higher mortality. The data tracks both ends of that spectrum.
  • Fistula rate — % of patient-months with fistula in use
  • Standardized Fistula Rate (SFR) — better, worse, or as expected
  • Long-term catheter rate — % of adult patients
  • Confidence intervals and patient counts for each summary
🦴
Mineral & Bone Disorder
Kidney failure disrupts calcium and phosphorus regulation, affecting bone density, cardiovascular risk, and calcification in blood vessels. CMS tracks two lab markers: hypercalcemia (elevated serum calcium, linked to vascular calcification) and serum phosphorus, reported in five concentration bands from too-low to dangerously high.
  • % of patients with hypercalcemia (serum calcium > 10.2 mg/dL)
  • Serum phosphorus — % of patients in each of 5 concentration ranges
  • Rolling 12-month patient and patient-month counts
  • State and national benchmarks for comparison
🚨
Emergency Department Encounters
Emergency department visits signal instability — a dialysis patient visiting the ED often means their condition deteriorated between scheduled sessions. CMS tracks two measures: the overall rate of ED encounters (SEDR), and ED visits within 30 days of a hospital discharge (ED30) — a potential indicator of gaps in post-hospitalization care coordination.
  • Standardized ED Encounter Ratio (SEDR) — actual vs. expected
  • ED encounters within 30 days of hospital discharge (ED30)
  • Category — better, worse, or as expected for both measures
  • Confidence intervals for both measures
🫀
Transplant Waitlisting
Kidney transplant is the only permanent path off dialysis. Two measures ask whether a facility is actively helping patients pursue it. The First Year Standardized Kidney Transplant Waitlist Ratio (FYSWR) tracks placement on the waitlist in a patient's first year of dialysis. The Percentage of Prevalent Patients Waitlisted (PPPW) measures how many of the facility's ongoing patients are currently listed.
  • First-year waitlist ratio (FYSWR) — better, worse, or as expected
  • % of prevalent patients currently on transplant waitlist (PPPW)
  • PPPW category — better, worse, or as expected
  • Confidence intervals for both measures
🩸
Hemoglobin & Modality
Two additional measures round out the dataset. Hemoglobin tracks anemia management — the percentage of patients with Hgb below 10 g/dL (under-treated) and above 12 g/dL (over-treated), both associated with worse outcomes. The Standardized Modality Switch Ratio (SMoSR) tracks whether patients are successfully transitioning between dialysis types — an indicator of a facility's ability to support patient-preferred treatment.
  • % of patients with hemoglobin below 10 g/dL
  • % of patients with hemoglobin above 12 g/dL
  • Standardized Modality Switch Ratio (SMoSR) — better, worse, or as expected
  • SMoSR confidence interval and eligible patient count

Where quality scores become payment adjustments.

The ESRD Quality Incentive Program (QIP) is Medicare's payment accountability mechanism for dialysis facilities. Each year, CMS evaluates facility performance across up to 17 measures and calculates a Total Performance Score (TPS) from 0 to 100. Facilities that score below the payment reduction threshold receive a cut to their Medicare reimbursement — up to 2% — applied to every dialysis session for an entire fiscal year.

Unlike the Five-Star rating, QIP scoring combines both achievement (absolute performance) and improvement (change since the baseline period). A facility that starts from a lower baseline and improves significantly can still earn a strong score — a design intended to reward progress, not just incumbency. The higher of a facility's achievement or improvement score for each measure counts toward the TPS.

ESRD QIP — Measures Across 3 Domains
Each measure produces an achievement score and an improvement score. The higher of the two applies to the Total Performance Score. Facilities below the threshold lose up to 2% of Medicare reimbursement for the following payment year — applied per session, for the full fiscal year.
Clinical Care
Outcomes & Clinical Measures
  • Kt/V dialysis adequacy — comprehensive
  • Standardized Hospitalization Ratio (SHR)
  • Standardized Readmission Ratio (SRR)
  • Standardized Transfusion Ratio (STrR)
  • % of prevalent patients waitlisted (PPPW)
  • Hypercalcemia
  • Vascular access — long-term catheter rate
Safety & Infection
Infection Prevention
  • NHSN bloodstream infection (BSI) in hemodialysis patients
  • NHSN dialysis event reporting
  • COVID-19 healthcare personnel vaccination
Patient & Care Experience
Experience, Equity & Coordination
  • ICH CAHPS patient experience composite
  • Clinical depression screening and follow-up
  • Medication reconciliation (MedRec)
  • Facility commitment to health equity (FCHE)

Where the data comes from and how often it is updated.

Dialysis facility quality data flows from two parallel CMS programs. The Dialysis Facility Care Compare (DFCC) dataset — produced by the University of Michigan Kidney Epidemiology and Cost Center on behalf of CMS — covers the Five-Star rating, all standardized ratios, lab measures, and ICH CAHPS results. This dataset is updated quarterly and covers over 7,600 active dialysis facilities.

ESRD QIP data is published separately through the CMS Provider Data Catalog and reflects each facility's annual performance scores and payment adjustment calculations. Because nearly all ESRD patients are covered by Medicare, the claims-based measures in both programs have unusually high completeness.

Most clinical measures use a rolling 12-month data collection window. The standardized mortality, hospitalization, readmission, and transfusion ratios typically reflect one to two years of data and use risk-adjustment models that account for patient age, diagnoses, time on dialysis, and dialysis modality — making cross-facility comparisons meaningful even when patient populations differ significantly.

Sources
  1. United States Renal Data System (USRDS) 2023 Annual Data Report — adr.usrds.org
  2. Data Dictionary for Quarterly Dialysis Facility Care Compare (QDFCC), October 2025 — University of Michigan Kidney Epidemiology and Cost Center on behalf of CMS — dialysisdata.org
  3. Data Dictionary for End-Stage Renal Disease Quality Incentive Program (ESRD QIP), January 2026 — CMS Provider Data Catalog
  4. CMS ESRD Measures Manual for the 2024 Performance Period, version 9.1 — CMS ESRD QIP Measuring Quality
  5. CMS Dialysis Facility Care Compare — Medicare Care Compare